What is it about?
Increasing the dose of anticholinergic can be safely done without compromising on safety in patients with stent related symptoms
Featured Image
Why is it important?
Stent related symptoms cause significant discomfort and are the most important cause of patient dissatisfaction in patients operated for ureteric stone disease. This makes them apprehensive for repeat Ureteroscopic surgeries which is quite common as stone disease has high recurrence rate.
Perspectives
This additional modification causes significant decrease in patient dissatisfaction resulting in patients accepting repeat surgeries in a better way.
maniyur raghavendran
Apollo Hospitals Enterprise
Read the Original
This page is a summary of: PD53-11 CAN INCREASED DOSE OF SOLIFENACIN BE AN ANSWER FOR STENT RELATED SYMPTOMS?, The Journal of Urology, April 2018, Elsevier,
DOI: 10.1016/j.juro.2018.02.2507.
You can read the full text:
Contributors
The following have contributed to this page
